Shandong Boan Biotechnology Co., Ltd. (HKG:6955)
Hong Kong
· Delayed Price · Currency is HKD 6.81
-0.06 (-0.87%)
At close: Apr 29, 2026
HKG:6955 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Revenue | 784.82 | 726.32 | 618.13 | 515.96 | 158.7 | Upgrade
|
| Revenue Growth (YoY) | 8.05% | 17.50% | 19.80% | 225.11% | - | Upgrade
|
| Cost of Revenue | 222.39 | 183.66 | 209.16 | 161.73 | 52.19 | Upgrade
|
| Gross Profit | 562.44 | 542.65 | 408.97 | 354.23 | 106.51 | Upgrade
|
| Selling, General & Admin | 382.08 | 332.3 | 308.22 | 296.42 | 96.21 | Upgrade
|
| Research & Development | 147.64 | 149.27 | 230.68 | 400.34 | 231.57 | Upgrade
|
| Operating Expenses | 529.72 | 481.58 | 538.9 | 696.76 | 327.78 | Upgrade
|
| Operating Income | 32.72 | 61.08 | -129.93 | -342.53 | -221.27 | Upgrade
|
| Interest Expense | -38.66 | -32.65 | -14.09 | -13.41 | -11.6 | Upgrade
|
| Interest & Investment Income | 4.49 | 0.41 | 1.16 | 5.57 | 9.1 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.03 | - | - | 2.38 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 7.22 | 44.36 | 23.49 | 16.24 | -1.65 | Upgrade
|
| EBT Excluding Unusual Items | 6.8 | 73.19 | -119.38 | -331.75 | -225.42 | Upgrade
|
| Other Unusual Items | 0.35 | - | - | - | - | Upgrade
|
| Pretax Income | 7.14 | 73.19 | -119.38 | -331.75 | -225.42 | Upgrade
|
| Net Income | 7.14 | 73.19 | -119.38 | -331.75 | -225.42 | Upgrade
|
| Net Income to Common | 7.14 | 73.19 | -119.38 | -331.75 | -225.42 | Upgrade
|
| Net Income Growth | -90.24% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 576 | 536 | 509 | 499 | 479 | Upgrade
|
| Shares Outstanding (Diluted) | 576 | 536 | 509 | 499 | 479 | Upgrade
|
| Shares Change (YoY) | 7.40% | 5.23% | 2.14% | 4.19% | 1119.88% | Upgrade
|
| EPS (Basic) | 0.01 | 0.14 | -0.23 | -0.67 | -0.47 | Upgrade
|
| EPS (Diluted) | 0.01 | 0.14 | -0.23 | -0.67 | -0.47 | Upgrade
|
| EPS Growth | -90.91% | - | - | - | - | Upgrade
|
| Free Cash Flow | - | -184.53 | -85.89 | -283.13 | -354.01 | Upgrade
|
| Free Cash Flow Per Share | - | -0.34 | -0.17 | -0.57 | -0.74 | Upgrade
|
| Gross Margin | 71.66% | 74.71% | 66.16% | 68.66% | 67.12% | Upgrade
|
| Operating Margin | 4.17% | 8.41% | -21.02% | -66.39% | -139.42% | Upgrade
|
| Profit Margin | 0.91% | 10.08% | -19.31% | -64.30% | -142.04% | Upgrade
|
| Free Cash Flow Margin | - | -25.41% | -13.89% | -54.87% | -223.06% | Upgrade
|
| EBITDA | 75.92 | 104.28 | -76.34 | -292.56 | -188.72 | Upgrade
|
| EBITDA Margin | 9.67% | 14.36% | -12.35% | -56.70% | -118.91% | Upgrade
|
| D&A For EBITDA | 43.2 | 43.2 | 53.59 | 49.97 | 32.55 | Upgrade
|
| EBIT | 32.72 | 61.08 | -129.93 | -342.53 | -221.27 | Upgrade
|
| EBIT Margin | 4.17% | 8.41% | -21.02% | -66.39% | -139.42% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.